Publications

January 1998 (Revised September 2001)
Case

Genset: 1989

By: Paul A. Gompers and Amy Burroughs

Discusses the start-up strategy at Genset, a French biotech firm. Pascal Brandys, a venture capitalist, and Marc Vasseur, a leading French scientist, must decide how to proceed. Future real options are central to the strategy. View Details

Keywords: Strategy; Venture Capital; Business Startups; Biotechnology Industry; France

June 1997 (Revised September 1997)
Case

Genset Initial Public Offering (B)

By: Paul A. Gompers and Jeffrey M. Anapolsky

Supplements the (A) case. View Details

Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States

March 2018 (Revised July 2018)
Case

Greenlight Biosciences: In Search of Impact Investment

By: Michael Chu, Annelena Lobb and Joni Coughlin

Greenlight Biosciences, a biotech company, is in search of impact investment for its next round of financing. View Details

Keywords: Impact Investment; Investment; Environmental Sustainability; Financing and Loans; Biotechnology Industry

November 2016
Case

Anthony Starks at InSiL Therapeutics (A)

By: Gary Pisano and Vicki Sato

When Bruce Wayne hired Anthony Starks, he thought he had hit a home run by getting the most brilliant and passionate scientist-leader in the field to be his CSO. But a few months in, Wayne and Starks begin to clash over crucial forward-looking decisions about the... View Details

Keywords: Biotech; Silicon; Managing Innovation; Management Challenges; Managing People; Managing Organization; R＆D; R＆D Project Management; Platform; Venture Capital; Drug Discovery; management; Biotechnology Industry; California

January 2012 (Revised August 2012)
Case

Dirigo International

By: Christopher M. Gordon and Chad M. Carr

Dirigo International is proposing a major expansion of their life sciences research and manufacturing facilities in the heart of a major city and middle to lower income residential neighborhood. The company and city government are seeking a development solution in the... View Details

Keywords: Production; Property; Expansion; Governing Rules, Regulations, and Reforms; Business and Government Relations; Research and Development; Outcome or Result; Biotechnology Industry

August 2010 (Revised August 2012)
Supplement

Generation Health: A Pioneer in Genetics Benefit Management (B)

By: Robert F. Higgins

Keywords: Health; Research and Development; Biotechnology Industry

January 2010 (Revised August 2011)
Case

Ganeden Biotech, Inc.

By: Robert C. Pozen, Dale Alan Winger and Matthew Kenneth Ahlers

The CEO of Ganeden Biotech, a small firm with several viable probiotic products but limited resources, must decide what markets to invest in and what intellectual property strategies will best serve its immediate and longer-term business interests. View Details

Keywords: Entrepreneurship; Investment; Intellectual Property; Market Entry and Exit; Business Strategy; Biotechnology Industry

November 2009 (Revised March 2010)
Case

Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story

By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon

In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details

Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States

July 2009
Teaching Note

Targanta Therapeutics: Hitting a Moving Target (TN)

By: Arthur A. Daemmrich

Teaching Note for [709002]. View Details

Keywords: Governing Rules, Regulations, and Reforms; Product Development; Business Strategy; Initial Public Offering; Mergers and Acquisitions; Policy; Selection and Staffing; Health Testing and Trials; Resource Allocation; Biotechnology Industry

May 2004
Teaching Note

Monsanto: Technology Cooperation and Small Holder Farmer Projects (TN)

By: James E. Austin and Diana Barrett

Teaching Note to (9-302-068). View Details

Keywords: Biotechnology Industry

November 2001 (Revised December 2002)
Case

Tracking Stocks at Genzyme (A)

By: Malcolm S. Salter

Genzyme, a tracking stock pioneer, has used its innovative capital structure as a way to frame and grow its R&D-intensive business. Facing the question of how best to integrate a new acquisition into its tracking stock structure, Genzyme's top management is forced to... View Details

Keywords: Integration; Value Creation; Motivation and Incentives; Conflict of Interests; Stocks; Capital Structure; Research and Development; Corporate Governance; Biotechnology Industry

Find at Harvard

October 2001
Case

TIGR and ILRI: Solving Problems with Genomics

By: Ray A. Goldberg and James M Beagle

Discusses nonprofit institutional leadership applying advances in genetic science to solve health and animal problems in industrial countries and the developing world. View Details

Keywords: Developing Countries and Economies; Health; Technological Innovation; Leading Change; Emerging Markets; Genetics; Non-Governmental Organizations; Technology Adoption; Biotechnology Industry